Onchocerciasis in pre-primary school children in Nigeria: lessons for onchocerciasis country control programme

Putative Autoantigen Leiomodin-1 Is Expressed in the Human Brain and in the Membrane Fraction of Newly Formed Neurons

Nodding syndrome is a pediatric epilepsy disorder associated with Onchocerca volvulus infection, but the mechanism driving this relationship is unclear. One hypothesis proposes that parasite-induced immune responses cross-react with human leiomodin-1 resulting in immune-mediated central nervous system (CNS) damage. However, as leiomodin-1 expression and epitope availability in human neurons remains uncharacterized, the relevance of leiomodin-1 autoimmunity is unknown. Leiomodin-1 transcript expression was assessed in silico using publicly available ribonucleic acid (RNA) sequencing databases and in tissue by in situ hybridization and quantitative polymerase chain reaction. Abundance and subcellular localization were examined by cell fractionation and immunoblotting. Leiomodin-1 transcripts were expressed in cells of the CNS, including neurons and astrocytes. Protein was detectable from all brain regions examined as well as from representative cell lines and in vitro differentiated neurons and astrocytes. Leiomodin-1 was expressed on the membrane of newly formed neurons, but not neural progenitor cells or mature neurons. Importantly, leiomodin-1 antibodies were only toxic to cells expressing leiomodin-1 on the membrane. Our findings provide evidence that leiomodin-1 is expressed in human neurons and glia. Furthermore, we show membrane expression mediates leiomodin-1 antibody toxicity, suggesting these antibodies may play a role in pathogenesis.

CD4(+), CD8(+), immunoglobulin status and ocular lesions among some onchocerciasis-infected rural Nigerians

CD4(+), CD8(+), immunoglobulin status and ocular lesions of some onchocerciasis-infected rural Nigerians as manifested by the presence of microfilariae in their skin snips and some chronic symptoms of the parasitic infestation were evaluated. The highest mean CD4(+) and mean microfilarial (mff) load of 560 +/- 20.46 unit cells/microl and 20 mff/mg were recorded among the individuals within the second decade of life, while the least mean CD4+ and mff load of 307.20 +/- 11.23 unit cell/microl and 6.5 mff/mg occurred among volunteers after 60 years of age. The highest mean CD8(+) of 388.00 +/- 23.71 unit cells/microl occurred at the third decade of life. The individuals above 60 years had the least mean CD8(+) of 350.25 +/- 11.90 unit cells/microl. The volunteers had mean CD4(+) of 372.45 +/- 109.02 unit cells/microl and mean CD8(+) of 359.42 +/- with an overall CD4(+):CD8(+) ratio of 1.04. The mean CD4(+) and mean CD8(+) had positive correlation with the mean microfilarial load (r = 0.52 and r = 0.40), respectively. The mean IgE, IgG, lgA, IgM, and IgD were 2,074.82 +/- 823.09, 19.36 +/- 2.49, 3.88 +/- 0.26, 3.59 +/- 0.38, and 0.29 +/- 0.19 mg/dl, and these immunoglobulins negatively correlated with the mean microfilarial load at r = -0.02, r = -0.15, r = -0.82, r = -0.37, and r = 0.26, respectively. Among these immunoglobulins evaluated, only mean IgE (2,074.82 +/- 823 ng/ml) was statistically different from the control subjects (0 mg/dl) at t = 3.39, P < 0.05. In all, the prevalence of the visual impairment and lesions were low. Among the six visual lesions, namely, cataract, choroidoretinitis, iridocyclitis, glaucoma, sclerosing keratitis, and optic atrophy encountered in Egoro-Eguare, only optic atrophy and sclerosing keratitis was reported among the children. The female adults had the highest prevalence of reduced vision 20(43.5%). Also, the prevalence of choroidoretinitis (2.2%) and iridocyclitis (2.2%) were the least prevalent ocular lesions reported among these female adults. The depletion of the CD4(+) contributed to the low prevalence of visual impairment and lesions in this locality. The depleted CD4(+), CD8(+), and the lower values of IgA, IgM, and IgG contributed in the maintenance of chronicity of onchocerciasis in Egoro-Eguare, Nigeria.

Human onchocerciasis: the essential partnership between research and disease control efforts

Twenty years ago onchocerciasis was a disease generally ignored by the medical world, except by those who actually worked with the affected people in Africa and Latin America. Now, largely as a result of the success of mass vector control and drug treatment programs, this is a disease management model for developing countries. The recent literature on onchocerciasis has, not surprisingly, mainly focused on various aspects of control. Investigation into the more basic questions is needed to ensure continued effective disease control. The present mass drug control program is based on a single pharmaceutical, ivermectin (Mectizan), which acts almost exclusively on the microfilarial stage of the infection. Efforts are being made to identify other useful drugs; however, no major candidates have yet appeared. The identification of potential biochemical targets for anti-filarial compounds through a better understanding of the biochemistry of these worms is being pursued. The Onchocerca volvulus endosymbiont Wolbachia may provide a target for therapeutic intervention. An improved understanding of the genomics of O. volvulus has made possible the identification of strain differences in the parasites, and an appreciation of the relevance of these strain differences to the clinical disease, onchocerciasis. There is a need for a better understanding of the clinical disease, and the various pathogenic mechanisms that underly the different syndromes. It is particularly important to understand the pathological basis and mechanisms underlying the adverse responses that can occur with chemotherapy. Present control programs now need to be carefully monitored for effectiveness using new assessment tools, such as antigen assays and the identification of organisms in pools of vectors. Current efforts to control onchocerciasis must be coordinated with new chemotherapy-based control programs for other worm diseases that are emerging. The results of laboratory studies are increasingly being applied to improve the effectiveness of field-based control programs and their assessment. Such research is essential for progress towards the goals of controlling and eliminating onchocerciasis.